These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 36122519)
1. Sirtuins as novel pharmacological targets in podocyte injury and related glomerular diseases. Liu T; Yang L; Mao H; Ma F; Wang Y; Li S; Li P; Zhan Y Biomed Pharmacother; 2022 Nov; 155():113620. PubMed ID: 36122519 [TBL] [Abstract][Full Text] [Related]
2. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling. Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079 [TBL] [Abstract][Full Text] [Related]
3. Emerging role of podocyte autophagy in the progression of diabetic nephropathy. Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of podocyte injury and implications for diabetic nephropathy. Barutta F; Bellini S; Gruden G Clin Sci (Lond); 2022 Apr; 136(7):493-520. PubMed ID: 35415751 [TBL] [Abstract][Full Text] [Related]
5. Sirtuin 6 protects against podocyte injury by blocking the renin-angiotensin system by inhibiting the Wnt1/β-catenin pathway. Miao H; Wang YN; Su W; Zou L; Zhuang SG; Yu XY; Liu F; Zhao YY Acta Pharmacol Sin; 2024 Jan; 45(1):137-149. PubMed ID: 37640899 [TBL] [Abstract][Full Text] [Related]
6. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects. Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883 [TBL] [Abstract][Full Text] [Related]
7. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Exacerbates Podocyte Injury and the Progression of Diabetic Kidney Disease. Qu H; Gong X; Liu X; Zhang R; Wang Y; Huang B; Zhang L; Zheng H; Zheng Y Diabetes; 2021 Jun; 70(6):1372-1387. PubMed ID: 33741719 [TBL] [Abstract][Full Text] [Related]
8. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy. Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385 [TBL] [Abstract][Full Text] [Related]
9. Metadherin orchestrates PKA and PKM2 to activate β-catenin signaling in podocytes during proteinuric chronic kidney disease. Chen X; Xiao J; Tao D; Liang Y; Chen S; Shen L; Li S; Zheng Z; Zeng Y; Luo C; Peng F; Long H Transl Res; 2024 Apr; 266():68-83. PubMed ID: 37995969 [TBL] [Abstract][Full Text] [Related]
10. Fn14 in podocytes and proteinuric kidney disease. Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007 [TBL] [Abstract][Full Text] [Related]
11. Understanding the podocyte immune responses in proteinuric kidney diseases: from pathogenesis to therapy. Jiang H; Shen Z; Zhuang J; Lu C; Qu Y; Xu C; Yang S; Tian X Front Immunol; 2023; 14():1335936. PubMed ID: 38288116 [TBL] [Abstract][Full Text] [Related]
12. Podocyte injury: the role of proteinuria, urinary plasminogen, and oxidative stress. Raij L; Tian R; Wong JS; He JC; Campbell KN Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1308-F1317. PubMed ID: 27335373 [TBL] [Abstract][Full Text] [Related]
14. Disrupting circadian control of autophagy induces podocyte injury and proteinuria. Wang L; Tian H; Wang H; Mao X; Luo J; He Q; Wen P; Cao H; Fang L; Zhou Y; Yang J; Jiang L Kidney Int; 2024 May; 105(5):1020-1034. PubMed ID: 38387504 [TBL] [Abstract][Full Text] [Related]
15. Protective effects of DPP-4 inhibitor on podocyte injury in glomerular diseases. Kubo A; Hidaka T; Nakayama M; Sasaki Y; Takagi M; Suzuki H; Suzuki Y BMC Nephrol; 2020 Sep; 21(1):402. PubMed ID: 32948146 [TBL] [Abstract][Full Text] [Related]
16. Sirt6 deficiency results in progression of glomerular injury in the kidney. Huang W; Liu H; Zhu S; Woodson M; Liu R; Tilton RG; Miller JD; Zhang W Aging (Albany NY); 2017 Mar; 9(3):1069-1083. PubMed ID: 28351995 [TBL] [Abstract][Full Text] [Related]
17. Interplay of lipid metabolism and inflammation in podocyte injury. Luo Z; Chen Z; Hu J; Ding G Metabolism; 2024 Jan; 150():155718. PubMed ID: 37925142 [TBL] [Abstract][Full Text] [Related]
18. [The role of podocyte injury in chronic kidney disease]. Asanuma K Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(1):26-36. PubMed ID: 25765686 [TBL] [Abstract][Full Text] [Related]
19. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury. Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113 [TBL] [Abstract][Full Text] [Related]
20. The E3 ligase Trim63 promotes podocyte injury and proteinuria by targeting PPARα to inhibit fatty acid oxidation. Chen Q; Xie C; Tang K; Luo M; Zhang Z; Jin Y; Liu Y; Zhou L; Kong Y Free Radic Biol Med; 2023 Nov; 209(Pt 1):40-54. PubMed ID: 37793501 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]